Recursion: CDK7 Inhibitor Differentiation Is Initially Paying Off
Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.
EatingWell on MSN4h
4 Anti-Inflammatory Proteins You Should Be Eating, According to a Dietitian
Reduce your risk of chronic disease and feel your best by adding these foods to your diet today.Inflammation may be a health ...
Hosted on MSN3h
The 7 Best Grains to Eat, According to Nutritionists
Grains are a staple in the kitchen, bringing flavor and nutrients, but which are the best grains to eat? We asked nutrition ...
Independent Record2h
Could obesity drugs help with alcohol cravings? New study suggests potential
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
Searching for willow ptarmigans in Ontario’s far north.
Some maintain a tally of observations in a certain county, province, or country. A portion of a birder’s regional list is ...
The New York Times23h
New York Times - Top Stories
Trump Says He Will Rework Global Trading Relations With ‘Reciprocal’ Tariffs President Trump signed a memorandum ordering his advisers to calculate new tariff levels for other countries, a ...